We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
2022-06-02
MD Anderson developed a platform to improve both antitumor immune responses and responses to checkpoint inhibitors
2022-06-01
